The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, LENZ Therapeutics Inc (NASDAQ: LENZ) closed at $26.34 down -3.09% from its previous closing price of $27.18. In other words, the price has decreased by -$3.09 from its previous closing price. On the day, 0.1 million shares were traded. LENZ stock price reached its highest trading level at $27.18 during the session, while it also had its lowest trading level at $26.1.
Ratios:
For a deeper understanding of LENZ Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.63 and its Current Ratio is at 28.63. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on September 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $37.
On August 12, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $38.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’24 when Chevallard Daniel R. bought 3,188 shares for $15.68 per share. The transaction valued at 49,988 led to the insider holds 3,188 shares of the business.
MCCOLLUM JAMES W bought 31,332 shares of LENZ for $501,093 on May 13 ’24. The Director now owns 525,565 shares after completing the transaction at $15.99 per share. On Mar 21 ’24, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 998,009 shares for $15.03 each. As a result, the insider paid 15,000,075 and bolstered with 3,319,339 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 724373696 and an Enterprise Value of 508844480.
Stock Price History:
Over the past 52 weeks, LENZ has reached a high of $38.93, while it has fallen to a 52-week low of $12.16. The 50-Day Moving Average of the stock is -18.24%, while the 200-Day Moving Average is calculated to be 12.40%.
Shares Statistics:
For the past three months, LENZ has traded an average of 154.39K shares per day and 135970 over the past ten days. A total of 27.48M shares are outstanding, with a floating share count of 22.36M. Insiders hold about 18.69% of the company’s shares, while institutions hold 71.99% stake in the company. Shares short for LENZ as of 1734048000 were 2264663 with a Short Ratio of 14.67, compared to 1731628800 on 2184601.
